TB Vaccine Development: Global Progress - A talk by Helen Mc Shane
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Julius Bruch.
Dr Helen McShane leads the TB vaccine programme at Oxford University and is working on a BCG challenge model. MVA85A , the original new TB vaccine she developed at Oxford, is currently in clinical trials in the UK, The Gambia, Senegal and South Africa and is one of the world’s leading new TB vaccines.
This talk is part of the Cambridge University Global Health Society series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|